公司表现 - Auna S A (AUNA) 今年以来股价上涨25 8%，远超医疗行业平均6 9%的涨幅 [4] - 公司所属的医疗服务行业(59家个股)平均涨幅为4 1%，AUNA表现显著优于同行 [5] - 另一家表现优异的医疗股BioMarin Pharmaceutical (BMRN) 年内涨幅为8 3% [4] 行业排名 - 医疗行业在Zacks 16个行业组别中综合排名第4 [2] - AUNA所属的医疗服务行业在Zacks行业排名中位列第83 [5] - BMRN所属的生物医学与遗传学行业(510家个股)排名第70，年内涨幅7 1% [6] 财务与评级 - AUNA当前Zacks评级为2(买入)，过去季度全年盈利预期上调8 3% [3] - BMRN同样获得Zacks 2评级，过去三个月全年EPS预期上调10 9% [5] - Zacks模型显示这两只股票未来1-3个月可能继续跑赢大盘 [3][5]

文章核心观点 - Auna S.A.（AUNA）股价过去四周上涨18.5%，华尔街分析师短期目标价显示其仍有上涨空间，但分析师设定目标价的能力和公正性存疑，投资者不应仅据此投资，公司盈利预期上调和Zacks排名显示其股价近期有上涨潜力 [1][3][9] 分析师目标价情况 - AUNA上一交易日收盘价8.72美元，华尔街分析师平均目标价12.15美元，有39.3%上涨潜力 [1] - 四个短期目标价从11美元到13美元不等，标准差0.87美元，最低估计涨幅26.2%，最乐观估计涨幅49.1%，标准差越小分析师共识越高 [2] 分析师目标价的问题 - 价格目标常误导投资者，分析师设定的目标价很少能指示股票实际走向 [5] - 许多分析师倾向设定过度乐观的目标价，因公司业务激励使其为有业务关系或想建立关系的公司抬高目标价 [6] - 投资者不应完全忽视目标价，但仅据此投资可能导致回报率不佳，应持高度怀疑态度 [8] AUNA股价上涨原因 - 分析师对公司盈利前景乐观，上调每股收益预期，盈利预期修正趋势与近期股价走势强相关 [9] - 今年过去30天有一个盈利预期上调且无下调，Zacks共识预期提高7.5% [10] - AUNA目前Zacks排名第二（买入），处于基于盈利预期四个因素排名的4000多只股票前20%，显示其股价近期有上涨潜力 [11]

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Auna S.A. (AUNA) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.Auna S.A. is a member of our Medical group, which includes 1010 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks ...

Editor's note: Seeking Alpha is proud to welcome Latin-American Investor as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.Hello! I am a latinamerican fundamentalist investor searching for discounted stocks across the region, but also worldwide. I have worked as a Portfolio Manager at a large financial institution and previously in invesment banking and ...

Exhibit 99.2 Condensed Consolidated Interim Financial Statements September 30, 2024 Auna S.A. and Subsidiaries Condensed Consolidated Interim Financial Statements September 30, 2024 | Contents | Page | | --- | --- | | Condensed Consolidated Interim Statement of Financial Position | 1 | | Condensed Consolidated Interim Statement of Income and Other | | | Comprehensive Income (Loss) | 2 | | Condensed Consolidated Interim Statement of Changes in Equity | 3 | | Condensed Consolidated Interim Statement of Cash F ...

Exhibit 99.2 Auna S.A. and Subsidiaries Condensed Consolidated Interim Financial Statements June 30, 2024 Auna S.A. and Subsidiaries Condensed Consolidated Interim Financial Statements June 30, 2024 | Contents | Page | | --- | --- | | Condensed Consolidated Interim Statement of Financial Position | 1 | | Condensed Consolidated Interim Statement of Income and Other | | | Comprehensive Income (Loss) | 2 | | Condensed Consolidated Interim Statement of Changes in Equity | 3 | | Condensed Consolidated Interim St ...

Exhibit 99.1 Auna Announces 1Q24 Financial Results Revenue increases 20% YoY to S/1,076 million, with operating profit increasing 26% to S/182 million Adjusted EBITDA margin of 20.4% in Peruvian operations Luxembourg, May 22, 2024 – Auna (NYSE: AUNA) ("Auna" or the "Company"), one of the largest and most recognized company in Latin America's healthcare industry with operations in Mexico, Colombia and Peru, today announced unaudited financial results for the three months ended March 31, 2024 ("first quarter ...